Rheumatic Diseases D012216

Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Connective Tissue Diseases » Rheumatic Diseases

Description

Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.   MeSH

Subtype Terms (8)

Arthritis, Juvenile
75 drugs (53 approved, 22 experimental)

Arthritis, Rheumatoid
530 drugs (211 approved, 319 experimental)

Fibromyalgia
120 drugs (75 approved, 45 experimental)

Gout
93 drugs (57 approved, 36 experimental)

Hyperostosis, Sternocostoclavicular
 

Osteoarthritis
301 drugs (135 approved, 166 experimental)

Polymyalgia Rheumatica
20 drugs (18 approved, 2 experimental)

Rheumatic Fever
11 drugs (5 approved, 6 experimental)


Phase 2 Indicated Drugs (2)

Other Experimental Indicated Drugs (1)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.